Balyasny Asset Management
PRVA icon

Balyasny Asset Management’s Privia Health PRVA Stock Holding History

Balyasny Asset Management’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-79,100
Closed -$1.82M – 3366
2025
Q2 		$1.82M Buy
+79,100
New +$1.83M ﹤0.01% 1787
2024
Q4 		– Sell
-11,889
Closed -$216K – 3164
2024
Q3 		$216K Sell
11,889
-11,767
-50% -$225K ﹤0.01% 2541
2024
Q2 		$411K Sell
23,656
-23,119
-49% -$410K ﹤0.01% 2127
2024
Q1 		$916K Buy
+46,775
New +$988K ﹤0.01% 1827
2022
Q3 		– Sell
-7,105
Closed -$207K – 3182
2022
Q2 		$207K Sell
7,105
-180,047
-96% -$4.58M ﹤0.01% 2196
2022
Q1 		$5M Buy
+187,152
New +$4.42M 0.02% 947

Other funds holding PRVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return
RF
Rubicon Founders Nashville, Tennessee $138M AUM 61.96% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.08B AUM 12.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Balyasny Asset Management's PRVA Position: Q3 2025 in Review

Balyasny Asset Management sold out of Privia Health (PRVA) in Q3 2025, closing a stake of 79,100 shares — an estimated $1.82M sold.

Balyasny Asset Management first reported a position in PRVA in Q1 2022 and held it in 6 quarters. The position peaked at $5M in Q1 2022. 259 funds tracked by Wall St. Rank hold PRVA as of Q3 2025.

  • Balyasny Asset Management reported no remaining Privia Health position as of Q3 2025 after selling out during the quarter.
  • Balyasny Asset Management sold 79,100 Privia Health shares in Q3 2025, an estimated $1.82M.
  • Balyasny Asset Management first reported a position in Privia Health in Q1 2022 and held it in 6 quarters.
  • Balyasny Asset Management's Privia Health position peaked at $5M in Q1 2022.
  • 259 funds tracked by Wall St. Rank held Privia Health as of Q3 2025.

Based on Balyasny Asset Management's 13F filing for Q3 2025, filed 14 Nov 2025.